• “Protein Biomarker Symposium 2019″/Core Lab Workshop

    Please note, that attendance at this event is strictly by invitation only, so please do not submit the registration form if you have not been personally invited  to do so.

    This symposium is sponsored and co-organized by Olink Proteomics and hosted by Professor Robert Gerszten (Harvard Medical School). We are delighted to welcome some of the leading experts in their fields to present exciting recent developments in the use of broad protein biomarker screening to drive advances in clinical research, wellness and drug development. These prestigious scientists will also share their knowledge and vision in a panel discussion to assess the current state and future development of precision medicine.


    Date: June 4, 2019
    Time: 9 am – 5 pm
    Location: Joseph B. Martin Conference Center at Harvard Medical School, Boston.

    Speakers and preliminary presentation titles:

    • Dr. Genevieve M. Boland, Harvard Medical School, Massachusetts General Hospital
      Tumor and blood-based markers of response and toxicity in melanoma immunotherapy”
    • Dr. Robert Gerszten, Harvard Medical School, Beth Israel Deaconess Medical Center
      “Mining the Blood for New Cardiometabolic Hormones”
    • Dr. Arthur Gilly, The Sanger Institute UK & The Helmholtz Center, Munich
      “Deep Whole-genome sequencing and the genetic architecture of the cardiometabolic proteome”
    • Dr. Steven Grinspoon, Harvard Medical School, Massachusetts General Hospital
      “Proteomic Approaches to Assess Novel Statin Effects in Health and Disease: Lessons Learned from the HIV Population”
    • Dr. Emma Guttman, Icahn School of Medicine at Mount Sinai, New York
      “The Skin and Blood Proteomic Profile of Atopic Dermatitis”
    • Dr. Jonas Halfvarson, Örebro University Sweden
      “Moving towards precision medicine in IBD”
    • Dr. Michael Howell, Incyte Corporation
      “Translational Approaches to Biomarker Identification in Acute Graft Versus Host Disease”
    • Dr. Anders Mälarstig,  Pfizer/SCALLOP consortium
      “Novel therapeutic candidates and disease biomarkers via large-scale protein QTL mapping in the SCALLOP consortium”
    • Dr. Svati Shah, Duke Medical School
      “Fibrosis Markers in Diastolic Dysfunction in Persons Living with HIV”
    • Dr. Charlotte Teunissen, Amsterdam University Medical Center
      “The earlier the better: need for body fluid biomarkers for dementias”
    • Dr. Lars Wallentin, Uppsala University
      “Emerging utility of multiple biomarkers in cardiovascular disease – an update 2019”

    More details and a full agenda will be uploaded as soon as all the details are confirmed.

    Participation is free, and lunch will be provided. There will also be an opportunity to discuss further with your colleagues at a social event that will take place in the evening, where we will be delighted to welcome you on board  an Odyssey cruise of Boston Harbor  (see more details here).

    If you are interested to see a short video summary of last year’s highly successful global meeting at the Nobel Forum in Sweden, please view it here.

    Core Lab Workshop June 5, 2019

    Olink Proteomics is also running a workshop, “Running the Olink platform”, which is by special invitation only for service providers and core labs who run Olink assays.  If you have received a personal invitation to this event, you can register for this and/or the June 4th symposium using the form below.

    Register below

    [contact-form-7 404 "Not Found"]